Source: Annual Congress 2002 - Asthma, COPD and management in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. L. Hazell, T. L. Frank, P. I. Frank (Manchester, United Kingdom). Healthcare utilisation, cost and respiratory disease severity. Eur Respir J 2002; 20: Suppl. 38, 2447

Member's Comments

No comment yet.

Related content which might interest you: Healthcare costs and resource use in patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada Source: Virtual Congress 2021 – Primary care organisation and epidemiology Year: 2021 Healthcare resource utilization and direct costs of interstitial lung disease management in Germany Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180078; 10.1183/16000617.0078-2018 Year: 2018 Healthcare utilisation in chronic cough Source: Virtual Congress 2020 – Increase in health care utilisation of modern treatments compared with the increase in effectiveness Year: 2020 Healthcare utilization and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Incidence, prevalence and healthcare utilization for respiratory complications of children with neuromuscular disease in Ontario, Canada Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 Canadian incidence, prevalence and healthcare utilization for respiratory complications of adults with neuromuscular disease Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 Trends in healthcare utilization and costs prior to a chronic obstructive pulmonary disease (COPD) diagnosis Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006 Persistent asthma: disease control, resource utilisation and direct costs Source: Eur Respir J 2002; 20: 260-267 Year: 2002 Profiling hospital performance to monitor the quality of care: the case of COPD Source: Eur Respir J 2010; 35: 1031-1038 Year: 2010 The hospital management of COPD exacerbations in the UK: does it conform to national guidance? Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Long-term evaluation of seasonal out-of-pocket medical costs in patients with chronic respiratory disease based on a survey Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Healthcare utilization and costs of pediatric home mechanical ventilation in Canada Source: International Congress 2019 – Epidemiology of childhood respiratory diseases Year: 2019 Integrated care prevents hospitalisations for exacerbations in COPD patients Source: Eur Respir J 2006; 28: 123-130 Year: 2006 Healthcare costs utilization and costs of patients hospitalized with acute respiratory distress syndrome (ARDS) in US commercially-insured individuals and Medicare beneficiaries Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Extent of uncontrolled disease and associated medical costs in severe asthma in the Netherlands Source: Annual Congress 2007 - Epidemiology of asthma Year: 2007 The effect of unit organisation and resources on outcomes of hospital admission for COPD exacerbations Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Asthma severity and medical resource utilisation Source: Eur Respir J 2004; 23: 723-729 Year: 2004 Quality of primary care management of chronic obstructive pulmonary disease (COPD) in south London: wide variation in prescribing and prevalence rates suggests inadequate care Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Asthma: prevalence and cost of illness Source: Eur Respir J 2005; 25: 47-53 Year: 2005